KINIKSA PHARMACEUTICALS LTD's ticker is KNSA and the CUSIP is G5269C101. A total of 99 filers reported holding KINIKSA PHARMACEUTICALS LTD in Q1 2022. The put-call ratio across all filers is 0.73 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $25,907,165 | +40.6% | 1,491,489 | +14.0% | 0.00% | +50.0% |
Q2 2023 | $18,427,102 | +29.2% | 1,308,743 | -1.3% | 0.00% | 0.0% |
Q1 2023 | $14,265,845 | +57.3% | 1,325,822 | +118.9% | 0.00% | +100.0% |
Q4 2022 | $9,071,049 | +42.7% | 605,544 | +22.3% | 0.00% | 0.0% |
Q3 2022 | $6,358,000 | +46.1% | 495,185 | +10.3% | 0.00% | 0.0% |
Q2 2022 | $4,351,000 | +67.2% | 448,895 | +71.4% | 0.00% | – |
Q1 2022 | $2,603,000 | -38.0% | 261,845 | -26.6% | 0.00% | -100.0% |
Q4 2021 | $4,199,000 | +44.3% | 356,764 | +39.7% | 0.00% | – |
Q3 2021 | $2,909,000 | -45.6% | 255,320 | -33.5% | 0.00% | -100.0% |
Q2 2021 | $5,348,000 | +62.2% | 383,934 | +115.5% | 0.00% | – |
Q1 2021 | $3,297,000 | -15.0% | 178,131 | -18.9% | 0.00% | -100.0% |
Q4 2020 | $3,881,000 | +26.4% | 219,660 | +9.6% | 0.00% | 0.0% |
Q3 2020 | $3,070,000 | +221.5% | 200,406 | +434.8% | 0.00% | – |
Q2 2020 | $955,000 | +365.9% | 37,476 | +182.6% | 0.00% | – |
Q1 2020 | $205,000 | -86.3% | 13,263 | -90.2% | 0.00% | – |
Q4 2019 | $1,501,000 | +63.0% | 135,752 | +25.4% | 0.00% | – |
Q3 2019 | $921,000 | +13.1% | 108,234 | +80.1% | 0.00% | – |
Q2 2019 | $814,000 | +15.8% | 60,098 | +54.2% | 0.00% | – |
Q1 2019 | $703,000 | +3.5% | 38,968 | +61.3% | 0.00% | – |
Q4 2018 | $679,000 | +16.9% | 24,160 | +6.2% | 0.00% | – |
Q3 2018 | $581,000 | +54.5% | 22,758 | +4.8% | 0.00% | – |
Q2 2018 | $376,000 | – | 21,721 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Spearhead Capital Advisors, LLC | 202,580 | $2,601,000 | 2.82% |
Lion Point Capital, LP | 480,000 | $5,140,000 | 1.13% |
HHLR ADVISORS, LTD. | 2,920,023 | $37,493,000 | 0.99% |
TANG CAPITAL MANAGEMENT LLC | 600,000 | $7,704,000 | 0.94% |
Rubric Capital Management LP | 1,446,107 | $18,568,000 | 0.94% |
AlphaCentric Advisors LLC | 43,000 | $552,000 | 0.57% |
RICE HALL JAMES & ASSOCIATES, LLC | 749,933 | $9,629,000 | 0.56% |
Parkman Healthcare Partners LLC | 126,192 | $1,620,000 | 0.46% |
Birchview Capital, LP | 30,000 | $385,000 | 0.27% |
Baker Brothers Advisors | 2,799,577 | $35,947,000 | 0.24% |